MXPA05008131A - Metodos para la modulacion de una respuesta inflamatoria. - Google Patents

Metodos para la modulacion de una respuesta inflamatoria.

Info

Publication number
MXPA05008131A
MXPA05008131A MXPA05008131A MXPA05008131A MXPA05008131A MX PA05008131 A MXPA05008131 A MX PA05008131A MX PA05008131 A MXPA05008131 A MX PA05008131A MX PA05008131 A MXPA05008131 A MX PA05008131A MX PA05008131 A MXPA05008131 A MX PA05008131A
Authority
MX
Mexico
Prior art keywords
modulating
methods
inflammatory response
wsx
animal
Prior art date
Application number
MXPA05008131A
Other languages
English (en)
Inventor
Alejandro Villarino
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/002646 external-priority patent/WO2004069173A2/en
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of MXPA05008131A publication Critical patent/MXPA05008131A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

El tema inventivo en cuestion se relaciona con metodos novedosos para modular una respuesta inmune en un animal, que comprenden administrar a dicho animal una cantidad efectiva de un agente que incrementa la actividad de IL-27R/WSX-1; adicionalmente, el tema inventivo en cuestion se relaciona con composiciones farmaceuticas que comprenden una cantidad efectiva de una agente que incrementa la actividad de IL-27R/WSX-1.
MXPA05008131A 2003-01-31 2004-02-02 Metodos para la modulacion de una respuesta inflamatoria. MXPA05008131A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US44449403P 2003-01-31 2003-01-31
US51907403P 2003-11-10 2003-11-10
PCT/US2004/002646 WO2004069173A2 (en) 2003-01-31 2004-01-30 Methods for modulating an inflammatory response
PCT/US2004/002767 WO2004069177A2 (en) 2003-01-31 2004-02-02 Methods for modulating an inflammatory response

Publications (1)

Publication Number Publication Date
MXPA05008131A true MXPA05008131A (es) 2005-10-05

Family

ID=32851399

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05008131A MXPA05008131A (es) 2003-01-31 2004-02-02 Metodos para la modulacion de una respuesta inflamatoria.

Country Status (2)

Country Link
MX (1) MXPA05008131A (es)
WO (1) WO2004069177A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4839434B2 (ja) * 2005-03-14 2011-12-21 千葉県 ｐ２８分子またはその遺伝子を含む医薬製剤
CA2661924A1 (en) * 2006-08-25 2008-02-28 Zymogenetics, Inc. Treatment of graft-versus-host disease
US20100008917A1 (en) * 2006-08-25 2010-01-14 Nancy Hosken Treatment of aplastic anemia
JP6175428B2 (ja) 2011-06-01 2017-08-02 イントレクソン・アクトバイオテイクス・エヌブイＩｎｔｒｅｘｏｎ Ａｃｔｏｂｉｏｔｉｃｓ ＮＶ 細菌のポリシストロン性発現系
DK3402499T3 (da) 2016-01-14 2021-09-27 Intrexon Actobiotics Nv Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes

Also Published As

Publication number Publication date
WO2004069177A3 (en) 2006-01-12
WO2004069177A2 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
MX2007003078A (es) Compuestos de imidazoquinolina.
WO2006069241A3 (en) Methods for promoting oral health in animals
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
TNSN07161A1 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2005004818A3 (en) Heterocyclic compounds and their use as anticancer agents
EP2349279A4 (en) ALDEHYDE DEHYDROGENASE MODULATORS AND METHOD OF USE THEREOF
EA200602137A1 (ru) Гидрогелевые препараты интерферона
MY150602A (en) Subtituted-quinoxaline-type piperidine compounds and the uses thereof
WO2004069173A3 (en) Methods for modulating an inflammatory response
EA201300246A1 (ru) Ингибиторы тирозинкиназы брутона
EP2592073A3 (en) Human protein tyrosine phosphatase inhibitors and their use
TW200637522A (en) Skin treatment articles and methods
EA201070611A1 (ru) Ингибиторы человеческой фосфатидилинозитол-3-киназы дельта
MX2010008726A (es) Composiciones y metodos para influir en la recuperacion a partir de actividad fisica intensa.
WO2005123116A3 (en) Compositions and methods for treating or preventing oxalate-related disease
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
TW200510373A (en) Substituted quinolin-4-ylamine analogues
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
MX2009008259A (es) Sistemas de ingredientes que comprenden trehalosa, productos alimenticios que contienen trehalosa y metodos para hacerlos.
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
WO2008051862A3 (en) Immunopotentiating compositions comprising beta-1,3/1,6-d-glucan and uses thereof
UA87692C2 (ru) Фармацевтическая композиция, содержащая рисперидон и распадающаяся при пероральном приеме
MXPA05008131A (es) Metodos para la modulacion de una respuesta inflamatoria.
WO2003105753A3 (en) METHODS AND COMPOSITIONS FOR GRAFTING FUNCTIONAL LOOPS INTO A PROTEIN
MXPA05008902A (es) Soluciones de drogas en mentol.

Legal Events

Date Code Title Description
FG Grant or registration